AF488 Anti-Human CD39 Antibody[A1]

Introducing the AF488 Anti-Human CD39 Antibody [A1], a highly specialized and meticulously crafted product designed to cater to the discerning needs of scientific research and diagnostic applications. This antibody, labeled with AF488, offers exceptional specificity and sensitivity in detecting the CD39 antigen in human samples.

The AF488 Anti-Human CD39 Antibody [A1] is meticulously developed using cutting-edge technology and rigorous quality control measures to ensure optimal performance and reliability. With its superior binding affinity and minimal cross-reactivity, this antibody guarantees accurate and precise results, making it an indispensable tool for various immunological studies.

This antibody is specifically engineered to target the CD39 antigen, a crucial cell surface marker involved in immune response modulation and inflammation regulation. By selectively recognizing and binding to CD39, this antibody enables researchers to investigate the role of CD39 in various physiological and pathological processes, including autoimmune diseases, cancer, and cardiovascular disorders.

The AF488 labeling of this antibody further enhances its versatility and convenience, allowing for direct visualization and quantification of CD39 expression in various experimental setups. The AF488 fluorophore exhibits exceptional brightness and photostability, ensuring reliable and reproducible imaging results.

The AF488 Anti-Human CD39 Antibody [A1] is supplied in a ready-to-use format, eliminating the need for time-consuming and error-prone conjugation procedures. Its compatibility with a wide range of applications, including flow cytometry, immunohistochemistry, and immunofluorescence, makes it an invaluable asset for researchers and clinicians alike.

In summary, the AF488 Anti-Human CD39 Antibody [A1] stands as a pinnacle of scientific excellence, offering unparalleled specificity, sensitivity, and convenience. With its exceptional performance and versatility, this antibody is poised to revolutionize the field of immunological research and diagnostic applications.